We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




High Omega-3's May Boost Risk of Aggressive Prostate Cancer

By HospiMedica International staff writers
Posted on 10 May 2011
A new study has found that men with the high levels of ω-3 docosahexaenoic acid (DHA) in their blood have a higher risk of developing aggressive, high-grade prostate cancer.

Researchers at the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) analyzed data from the US Prostate Cancer Prevention Trial, a randomized clinical trial that tested the efficacy of the drug finasteride to prevent prostate cancer. More...
The trial involved nearly 19,000 men age 55 and older, but the data for the analysis came from a subset of more than 3,400 of the study participants, half of whom developed prostate cancer during the course of the study and half of whom did not. Phospholipid fatty acids were extracted from serum of the patients, and concentrations of ω-3, ω-6, and trans-fatty acids (TFAs) were expressed as proportions of the total.

The researchers found that men with the highest blood percentages of DHA--an inflammation-lowering ω-3 fatty acid commonly found in fatty fish--have two-and-a-half-times the risk of developing prostate cancer compared to men with the lowest DHA levels. The study also found that men with the highest blood ratios of TFAs--linked to inflammation and heart disease and abundant in processed foods that contain partially hydrogenated vegetable oils--had a 50% reduction in the risk of high-grade prostate cancer. The researchers also found that ω-6 fatty acids--found in most vegetable oils and linked to inflammation and heart disease--were not associated with prostate cancer risk. The study was published ahead of print on April 24, 2011, in the American Journal of Epidemiology.

"Our findings turn what we know or rather what we think we know about diet, inflammation and the development of prostate cancer on its head and shine a light on the complexity of studying the association between nutrition and the risk of various chronic diseases,” said lead author Theodore Brasky, PhD, and colleagues in the Public Health Sciences Division. "Besides inflammation, ω-3 fats affect other biologic processes. It may be that these mechanisms play a greater role in the development of certain prostate cancers. This is certainly an area that needs more research.”

"Overall, the beneficial effects of eating fish to prevent heart disease outweigh any harm related to prostate cancer risk,” added Dr. Brasky. "What this study shows is the complexity of nutrition and its impact on disease risk, and that we should study such associations rigorously rather than make assumptions.”

Related Links:
Fred Hutchinson Cancer Research Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.